Several GLP-1 receptor agonists have demonstrated cardiovascular benefits in specific populations, with varying magnitudes of risk reduction for major adverse cardiovascular events in landmark trials
The FDA gave the green light to semaglutide (under the brand name Wegovy) in June of 2021 for weight management for adults with obesity or overweight accompanied by at least one weight-related condition, such as elevated blood pressure, type 2 diabetes, or high cholesterol
However, it is important to keep track of the changes to your side effects and get medical attention if they worsen
According to some publications, the extent and the intensity of physiological oral mucosal melanin hyperpigmentation increase with age probably owing to the cumulative effects of endogenous and extrinsic melanogenic stimuli, such as inflammatory processes, drugs, tobacco smoke, and recurrent minor functional injuries [4, 6, 11, 13]
Output files were visualized in UCSF Chimera using the volume series function and captured as movies
Obici says